NCT03613740View on ClinicalTrials.gov

Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

January 30, 2022

Study Completion Date

July 30, 2023

Conditions
Metabolic Syndrome
Interventions
DRUG

Fucoxanthin

Intervention will be administered 30 minutes before breakfast.

DRUG

Placebo

Intervention will be administered 30 minutes before breakfast.

Trial Locations (1)

44340

Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | Biotech Hunter | Biotech Hunter